73 related articles for article (PubMed ID: 37046698)
21. The clinical features and management of Lynch syndrome-associated ovarian cancer.
Ran X; Jing H; Li Z
J Obstet Gynaecol Res; 2022 Jul; 48(7):1538-1545. PubMed ID: 35478369
[TBL] [Abstract][Full Text] [Related]
22. SPOCK1 silencing decreases 5-FU resistance through PRRX1 in colorectal cancer.
Qu YL; Liu XL; Zhao SY; Zhai XF
Pathol Res Pract; 2022 Jun; 234():153895. PubMed ID: 35462225
[TBL] [Abstract][Full Text] [Related]
23. SPOCK1 with unexpected function. The start of a new career.
Váncza L; Tátrai P; Reszegi A; Baghy K; Kovalszky I
Am J Physiol Cell Physiol; 2022 Apr; 322(4):C688-C693. PubMed ID: 35235422
[TBL] [Abstract][Full Text] [Related]
24. SPOCK1 Promotes the Development of Hepatocellular Carcinoma.
Váncza L; Karászi K; Péterfia B; Turiák L; Dezső K; Sebestyén A; Reszegi A; Petővári G; Kiss A; Schaff Z; Baghy K; Kovalszky I
Front Oncol; 2022; 12():819883. PubMed ID: 35186754
[TBL] [Abstract][Full Text] [Related]
25. Anti-miR-135/SPOCK1 axis antagonizes the influence of metabolism on drug response in intestinal/colon tumour organoids.
Babaei-Jadidi R; Kashfi H; Alelwani W; Karimi Bakhtiari A; Kattan SW; Mansouri OA; Mukherjee A; Lobo DN; Nateri AS
Oncogenesis; 2022 Jan; 11(1):4. PubMed ID: 35046388
[TBL] [Abstract][Full Text] [Related]
26. Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.
Lánczky A; Győrffy B
J Med Internet Res; 2021 Jul; 23(7):e27633. PubMed ID: 34309564
[TBL] [Abstract][Full Text] [Related]
27. Multiomic analysis of the function of
Han J; Rong Y; Gao X
J Int Med Res; 2021 Jun; 49(6):300060520962659. PubMed ID: 34156309
[TBL] [Abstract][Full Text] [Related]
28. SPOCK1 promotes the proliferation and migration of colon cancer cells by regulating the NF-κB pathway and inducing EMT.
Liu HX; Cao YY; Qu JY
Neoplasma; 2021 Jul; 68(4):702-710. PubMed ID: 33884883
[TBL] [Abstract][Full Text] [Related]
29. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.
Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z
Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473
[TBL] [Abstract][Full Text] [Related]
30. Heparan Sulfate Proteoglycans Biosynthesis and Post Synthesis Mechanisms Combine Few Enzymes and Few Core Proteins to Generate Extensive Structural and Functional Diversity.
Annaval T; Wild R; Crétinon Y; Sadir R; Vivès RR; Lortat-Jacob H
Molecules; 2020 Sep; 25(18):. PubMed ID: 32937952
[TBL] [Abstract][Full Text] [Related]
31. SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy?
Sun LR; Li SY; Guo QS; Zhou W; Zhang HM
Cancer Manag Res; 2020; 12():3561-3569. PubMed ID: 32547193
[TBL] [Abstract][Full Text] [Related]
32. SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway.
Du Z; Lin Z; Wang Z; Liu D; Tian D; Xia L
Lab Invest; 2020 Aug; 100(8):1042-1056. PubMed ID: 32291390
[TBL] [Abstract][Full Text] [Related]
33. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
Li J; Ke J; Fang J; Chen JP
J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
[TBL] [Abstract][Full Text] [Related]
34. Novel Approaches to Ovarian Cancer Screening.
Nebgen DR; Lu KH; Bast RC
Curr Oncol Rep; 2019 Jul; 21(8):75. PubMed ID: 31346778
[TBL] [Abstract][Full Text] [Related]
35. High SPOCK1 Expression is Associated with Advanced Stage, T Value, and Gleason Grade in Prostate Cancer.
Chen ML; Ho CJ; Yeh CM; Chen SL; Sung WW; Wang SC; Chen CJ
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31284511
[TBL] [Abstract][Full Text] [Related]
36. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
37. SPOCK1 contributes to the third-generation EGFR tyrosine kinase inhibitors resistance in lung cancer.
Gao Y; Yu M; Ma M; Zhuang Y; Qiu X; Zhao Q; Dai J; Cai H; Yan X
J Cell Biochem; 2019 Aug; 120(8):12566-12573. PubMed ID: 30825234
[TBL] [Abstract][Full Text] [Related]
38. Correlation between SPARC, TGFβ1, Endoglin and angiogenesis mechanism in lung cancer.
Wang B; Zhang Z; Tang J; Tao H; Zhang Z
J Biol Regul Homeost Agents; 2018; 32(6):1525-1531. PubMed ID: 30574760
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and Treatment of Ovarian Cancer.
Orr B; Edwards RP
Hematol Oncol Clin North Am; 2018 Dec; 32(6):943-964. PubMed ID: 30390767
[TBL] [Abstract][Full Text] [Related]
40. Reduced SPOCK1 expression inhibits non-small cell lung cancer cell proliferation and migration through Wnt/β-catenin signaling.
Wang T; Liu X; Tian Q; Liang T; Chang P
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):637-644. PubMed ID: 29461591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
